Erratum. Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 2016;39:2042-2050

Lennart Tonneijck, Mark M Smits, Marcel H A Muskiet, Trynke Hoekstra, Mark H H Kramer, A H Jan Danser, Piet M Ter Wee, Michaela Diamant, Jaap A Joles, Daniel H van Raalte

Research output: Contribution to JournalArticleAcademicpeer-review

Original languageEnglish
JournalDiabetes Care
DOIs
Publication statusE-pub ahead of print - 23 Jan 2019

Cite this

Tonneijck, Lennart ; Smits, Mark M ; Muskiet, Marcel H A ; Hoekstra, Trynke ; Kramer, Mark H H ; Danser, A H Jan ; Ter Wee, Piet M ; Diamant, Michaela ; Joles, Jaap A ; van Raalte, Daniel H. / Erratum. Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes : a 12-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 2016;39:2042-2050. In: Diabetes Care. 2019.
@article{f342d324fb4046fb9c0795eedf7abbbd,
title = "Erratum. Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 2016;39:2042-2050",
author = "Lennart Tonneijck and Smits, {Mark M} and Muskiet, {Marcel H A} and Trynke Hoekstra and Kramer, {Mark H H} and Danser, {A H Jan} and {Ter Wee}, {Piet M} and Michaela Diamant and Joles, {Jaap A} and {van Raalte}, {Daniel H}",
year = "2019",
month = "1",
day = "23",
doi = "10.2337/dc19-er03",
language = "English",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",

}

Erratum. Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes : a 12-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 2016;39:2042-2050. / Tonneijck, Lennart; Smits, Mark M; Muskiet, Marcel H A; Hoekstra, Trynke; Kramer, Mark H H; Danser, A H Jan; Ter Wee, Piet M; Diamant, Michaela; Joles, Jaap A; van Raalte, Daniel H.

In: Diabetes Care, 23.01.2019.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Erratum. Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes

T2 - a 12-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 2016;39:2042-2050

AU - Tonneijck, Lennart

AU - Smits, Mark M

AU - Muskiet, Marcel H A

AU - Hoekstra, Trynke

AU - Kramer, Mark H H

AU - Danser, A H Jan

AU - Ter Wee, Piet M

AU - Diamant, Michaela

AU - Joles, Jaap A

AU - van Raalte, Daniel H

PY - 2019/1/23

Y1 - 2019/1/23

U2 - 10.2337/dc19-er03

DO - 10.2337/dc19-er03

M3 - Article

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

ER -